GOOGLE MUST FACE SUIT OVER SCANNING OF MESSAGES IN GMAIL, JUDGE RULES

Los Angeles Times
By:  Jessica Guynn
September 26, 2013

A San Jose federal judge has ruled that Google must face a lawsuit that accuses the tech giant of illegally opening and reading the contents of email sent through its Gmail service in violation of federal wiretapping statutes.

“The court finds that it cannot conclude that any party – Gmail users or non-Gmail users – has consented to Google’s reading of email for the purposes of creating user profiles or providing targeted advertising,” U.S. District Judge Lucy Koh wrote in her ruling.

Google says it automatically scans emails to target advertising based on words that appear in Gmail messages but says that machines, not people, do the scanning.

“We’re disappointed in this decision and are considering our options,” Google said in an emailed statement.  Automated scanning lets us provide Gmail users with security and spam protection, as well as great features.”

Gmail users have filed seven lawsuits that have been consolidated into one.

Koh granted Google’s request to throw out claims filed under state law, but is allowing plaintiffs to refile those claims.

She refused to dismiss claims filed under federal law.  Google had argued that users agree to let Google read emails by accepting the service’s terms and privacy policy.

Google said in court papers that email users must expect “automated processing” of emails and that the lawsuit is seeking to “criminalize ordinary business practices that have been part of Google’s free Gmail service since it was introduced nearly a decade ago.”

Privacy watchdog Marc Rotenberg called the ruling “a major victory for Internet privacy.”

“Google will no longer be able to peer into everyone’s email,” said Rotenberg, executive director of the Electronic Privacy Information Center.

A federal appeals court earlier this month refused to dismiss a civil lawsuit accusing Google of violating federal wiretapping laws when its fleet of Street View cars inadvertently swept up emails, passwords and other highly sensitive personal information from unencrypted wireless networks.

The 9th U.S. Circuit Court of Appeals ruled that Google could be held liable for damages for intercepting the personal data from unsuspecting households while photographing streets for its popular street-mapping service.

CAN STATE AGs SUE AFTER NATIONWIDE CLASS ACTION SETTLEMENT?

http://newsandinsight.thomsonreuters.com/Legal/News/2012/08

I’ve written a lot this year about a worrisome trend for class action lawyers: state attorneys general swooping into well-developed cases and settling them out from under the class lawyers who sank vast amounts of time and money into the litigation.  We saw it in the muni bond derivatives litigation, we’re seeing it in the e-books antitrust case, and I’d wager that the Libor subpoenas sent to banks by the New York and Connecticut AGs are a prelude to claims that could bump up against the ongoing Libor antitrust class action.

But here’s a twist on the paradigm: On Tuesday, U.S. District Judge Virginia Covington of Tampa, Florida, ruled that Capital One’s $250 million nationwide class action settlement does not bar subsequent parents patriae suits against the credit card company by state AGs – even though the class settlement specifically includes releases of those claims.  And to add to the frustration for Capital One and its lawyers at Morrison & Foerster, one of the private firms representing the AGs also represented plaintiffs in the class action.

According to Covington’s nine-page decision, Capital One cardholders first sued over the company’s “payment protection” fees in 2007 and reached a nationwide class action settlement in 2010.  The settlement agreement specifically released all “claims on [cardholders’] behalf (including the government in its capacity in parens patriae).” Yet in April and June of 2012, the AGs of Hawaii and Mississippi filed state-court parens patriae suits against Capital One, citing the same payment protection fees at issue in the class action.

Capital One asked Covington to enjoin the AGs’ suits, arguing that their claims had already been litigated and resolved in the case she oversaw.  The credit card company’s brief also asked the Florida judge to sanction the firm Golomb & Honik, which had been counsel to plaintiffs in the class action and subsequently signed on as counsel to the Hawaii and Mississippi AGs.  “Golomb’s conduct in asserting against Capital One claims released herein violates Golomb’s obligations under the settlement agreement approved by this court,” asserted Capital One’s MoFo lawyers, requesting an order that the plaintiffs’ firm pay Capital One’s legal fees.

Golomb & Honik replied that the class action settlement didn’t release the AGs’ claims because class members don’t’ have authority to do so.  Individual cardholders, the firm argued in a 24-page brief, can’t sign away the state’s rights, and Capital One knows it.  Otherwise, according to the brief, the credit card company would not have agreed to a $13.5 million settlement with the West Virginia AG in January 2012 to resolve the same payment protection fee claims that were raised in the class action.  “Why would Capital One agree to pay West Virginia and its citizens directly to settle claims regarding payment protection for an overlapping period of time and yet argue to Your Honor that all claims that an AG could bring have been released?” the Golomb brief said.  (The firm also asserted that it had done nothing to warrant sanctions, since it had not acted in any way to undermine the class settlement.)

In her ruling Tuesday, Covington sided with Golomb and the Mississippi AG, who also filed a brief in opposition to Capital One.  “The court’s order approving the settlement and closing this case did not bind the States of Mississippi and Hawaii,” she wrote.  “The (AGs) of Mississippi and Hawaii were not defined as class members and did not have an opportunity to participate in the litigation or opt out of the class.  It would be a violation of the Due Process clause to now enjoin such Attorney General via the requested injunction.”  And if Capital One wants to argue that the AGs’ claims are already resolved, she said, it should make that argument before the Hawaii and Mississippi judges hearing the AG cases, not to her.  (She also denied sanctions, without explanation.)

Richard Golomb told me Covington got the analysis exactly right.  He said there have been several other instances in which AGs have filed suits following class action settlements.  “Banks tried this same maneuver and failed each time,” he said.  I asked why the class settlement included language on the release of parens patriae claims if, in his view, that language is meaningless.  “I didn’t draft the release,” he said.

I left a message for Capital One counsel James McCabe of MoFo but didn’t immediately hear back.

(Reporting by Alison Frankel)

Federal Judge Certifies $23.5 Mil. Class Settlement With HSBC

November 21, 2012

Legal Intelligencer

 

A federal judge has given final certification to a $23.5 million class settlement with HSBC in a case in which the plaintiffs alleged that the bank acted deceptively in administering its “debt cancellation” and “debt suspension” plans.

Over the objections from three states’ attorneys general, U.S. District Senior Judge Berle Schiller of the Eastern District of Pennsylvania approved the settlement, finding nearly all of the factors that courts are required to consider weighed in favor of the settlement.  The attorneys general for Hawaii, Mississippi and West Virginia aren’t members of the class, so they don’t’ have standing to object, Schiller said.

He explained in a footnote, “Because they are not class members, the AG’s may continue to bring claims belonging to their respective states, such as state criminal and regulatory actions.”  However, Schiller specified that members of this class settlement won’t be able to “double recover” on state actions.

Richard Golomb, of the Philadelphia class-action law firm of Golomb & Honik, represented the plaintiffs in the Eastern District case, Esslinger v. HSBC, and said of the objections from the attorneys general, “It’s the first time this has ever occurred.”  This settlement agreement applied to six cases, including ones in California, Washington, New Jersey and two in different districts of Illinois.

The states were reasonably taking a “belt and suspenders” approach.  Golomb said, explaining that they wanted to make sure that their state claims could survive.

Schiller’s reasoning in answering the objections was sound, both legally and equitably, Golomb said.

“The most common complaint was that the settlement amount was insufficient to compensate the individual objector for his or her estimated losses,” Schiller said.  “While the court is sympathetic to the objectors’ individual experiences, a settlement is, by its nature, a compromise.

“Considering the legal and factual obstacles that plaintiffs must surmount to prove their claims, the class members face a serious risk of recovering nothing without the settlement.  Likewise, the fact that the objectors represent a fraction of 1 percent of the overall class strongly favors settlement.”

Most members of the class will get between $15 and $60.  Anyone who was enrolled in HSBC’s “debt cancellation” or “debt suspension” programs, which would suspend or eliminate his or her credit car payments if he or she were to lose his or her job or become temporarily disabled for a monthly fee that was usually less than $200 between July 2, 2004, and February 22, 2012, can be a part of the class, according to the opinion.

Schiller found that all but one of the factors in each of the two tests he applied weighed toward approving the settlement.

He first discussed the nine Girsh factors, from the U.S. Court of Appeals for the third Circuit’s 1975 opinion in Girsh v. Jepson, and then, briefly, the Prudential factors, from the Third circuit’s 1998 opinion in In re Prudential Insurance.

“All of the Girsh and Prudential factors are neutral or weigh in favor of settlement, with the exception of whether defendants could withstand a greater judgment,” Schiller said.

“This court believes that the settlement represents a fair compromise between two parties seeking to end litigation whose outcome is murky and uncertain.”

Because HSBC is a multinational bank operating in more than 88 countries, it could probably survive a larger judgment, Schiller said.  However, that’s the only factor that he found against the approval of the settlement.

Notably, no formal discovery had yet taken place, although there had been cooperation between the parties with HSBC giving thousands of pages of documentation to the class’s counsel.

Schiller awarded 30 percent of the settlement amount as attorney fees, which nearly met the class counsel’s request of $7.7 million.  The percentage-of-recovery method that Schiller chose to determine the amount of attorney fees netted them $7.1 million.  He also awarded them costs of about $101,000.

Nearly all 10 of the Circuit’s factors for weighing the suitability of attorney fees weighed in favor of 30 percent of the settlement, Schiller found, with only the final factor, considering how innovative the terms of the agreement were, weighing in as neutral.

“The court finds that a 30 [percent] fee, a reduction from class counsel’s requested percentage of approximately 33 [percent], is a fair recovery considering the size of the fund and number of beneficiaries,” Schiller said, citing an opinion from his court earlier this month in In re Processed Egg Products Antitrust Litigation, which had approved a 30 percent attorney fee award on a $25 million settlement.

Andrew Stutzman of Stradley Ronon Stevens & Young in Philadelphia represented HSBC and couldn’t be reached for comment.

 

PNC Among Banks Changing Policies Following Lawsuits Over Overdraft Charges

Pittsburgh Post-Gazette

PNC Bank customers who may overdraw their checking accounts are getting some good news.

Starting Dec. 1, Pittsburgh’s biggest bank will stop reordering checks and debit card transactions from highest amount to lowest, a practice long decried by consumer groups as a sneaky way to maximize overdraft fees.

Under the new policy, checks and debit transactions will be processed in the order they come in.

Earlier this year, PNC agreed to pay $90 million to settle a federal class-action lawsuit that accused big banks nationwide of improperly manipulating debit card purchases by re-sequencing them and clearing them from high to low.  That practice tends to drain an account more quickly and trigger the most overdraft fees, which now average about $35 a pop.

PNC spokesman Pat McMahon said the policy change was in the works before June’s settlement agreement.

The class-action suit, which is pending in U.S. District Court in Miami and involves some three dozen big banks (about one-third have settled so far), does not cover the way the banks process checks, only debit card transactions.  Nevertheless, PNC’s new policy will extend to checks.

With the switch, PNC joins First Commonwealth, Northwest Savings and ESB among the region’s top 10 retail banks in processing checks and debit card transactions in a manner favored by consumer groups.

Like PNC’s new policy, Northwest Savings and ESB clear both types of transactions in the order they are presented, while First Commonwealth processes checks in order and debit transactions from lowest amount to highest.

Capital One Loses Bid to Block State AG Suits Over Payment Protection

Dow Jones Newswires

By:  Andrew R. Johnson

A federal judge has denied Capital One Financial Corp.’s (COF) efforts to block state regulators’ lawsuits over payment-protection products marketed to credit-card customers.

Payment protection, also known as credit protection, has come under increased regulatory scrutiny amid claims that lenders have mischaracterized product features and enrolled customers in the services, which carry monthly fees, without their permission.  Capital One in July agreed to pay $210 million to settle similar allegations brought by the Consumer Financial Protection Bureau and Office of the Comptroller of the Currency.

Separately, the McLean, VA.-based bank sought injunctions earlier this month against the attorneys general for Mississippi and Hawaii, who have filed lawsuits in recent months against Capital One over its sales practices for payment protection.

The request was made in a motion filed in U.S. District Court for the Middle District of Florida, which approved a settlement in 2010 over a federal class-action lawsuit in which customers claimed the bank enrolled them in payment protection without their permission.

“If allowed to proceed, the Attorneys General suits will ‘unsettle’ that which has been settled and will cast doubt on the finality” of the district court’s rulings in the previous case, attorneys for Capital One argued in their Aug. 3 motion.

But U.S. District Court Judge Virginia Hernandez Covington denied Capital One’s requests in an order filed Wednesday, calling the bank’s requests “inappropriate.”

The federal court’s approval of the 2010 settlement “did not bind the States of Mississippi and Hawaii” because they weren’t defined as class members in that case and “didn’t have an opportunity to participate in the litigation or opt out of the class.”  Preventing the states from bringing their suits would violate their due process, she stated.

Capital One spokeswoman Tatiana Stead didn’t have an immediate comment when contacted Friday.

Banks have marketed payment protection as a safety net cardholders can rely upon if they lose their jobs, encounter health problems or incur another hardship that prevents them from making their minimum monthly payment.  The service is supposed to suspend a borrower’s minimum monthly payments for a certain period of time if such an event occurs.

As part of the 2010 settlement, Capital One agreed to pay up to $250 million to credit-card customers who had payment protection, though they ultimately received about $60 million, based on the number of customers who opted in to the deal, Richard Golomb, an attorney with the law firm of Golomb & Honik, PC, said Friday.  The law firm helped represent the plaintiffs in the case and is serving as private counsel to Mississippi and Hawaii in their cases.

Capital One also sought sanctions against Golomb & Honik as part of its motion, arguing the firm’s representation of the two states “exhibit willful disobedience of the order” approving the 2010 settlement and “should be penalized.”

In her Wednesday order, the judge declined to issue sanctions against Golomb & Honik.

Hawaii AG David Louie filed a suit against Capital One in April, while Mississippi AG Jim Hood did so in June.  Both actions allege that bank has failed to accurately disclose the terms and conditions of payment-protection products to customers and determine if customers actually qualify for the service before enrolling them.

West Virginia AG Darrell McGraw in January said Capital One agreed to pay $13.5 million to settle a similar case.

Several large banks recently said they have halted sales of payment protection.

Bank of America Corp. (BAC) stopped selling credit protection to its credit-card customers earlier this month and plans to phase it out for existing cardholders enrolled in the service sometime next year, the bank said this week.  Bank of America agreed this summer to pay $20 million to settle a federal class-action lawsuit in which Golomb & Honik was also involved.

J.P. Morgan Chase & Co. (JPM) stopped offering the product to new customers last October.  Citigroup Inc. (C) has temporarily stopped selling the product over the phone while it reviews the product to ensure it is in line with recent guidance from the CFPB, a spokeswoman said this week.

Capital One said last month it had stopped offering payment protection and a credit monitoring product after it agreed to pay the CFPB and OCC $60 million in fines stemming from claims that its third-party sales agents mismarketed the products.  The bank also agreed to refund $150 million to customers.

Discover Financial Services (DFS) is facing a joint-enforcement action by the CFPB and Federal Deposit Insurance Corp. over its marketing of payment protection and other add-on products, the company has said in regulatory filings.

 

 

 

Bank of America, Others to End Debt-Protection Products

Bank of America Corp. (BAC) and other banks have stopped selling add-on products to credit-card customers that suspend borrowers’ minimum monthly payments in the event of a job loss or other hardship, as regulatory scrutiny of these offerings grows.

Debt-cancellation products, also known as payment or credit protection, have also sparked class-action lawsuits against the country’s largest credit –card issuers and let to a $210 million settlement last month between Capital One Financial Corp. (COF) and federal regulators.

Bank of America stopped offering products called Credit Protection Plus and Credit Protection Deluxe to new customers this month but is continuing to provide them to existing cardholders enrolled in the services, said Betty Riess, a spokeswoman for Bank of America.  The bank plans to end the service for those customers some time next year, she said.

Capital One has stopped offering payment-protection and credit-monitoring products, and Citigroup Inc. (C) has halted new telephone sales of payment protection products while it reviews its products.  J.P. Morgan Chase & Co. (JPM) ended sales of payment-protection products to new customers last year.

Bank of America’s decision to discontinue the products, which are provided by third-party vendors, is part of the bank’s “larger strategy to streamline our business,”  Ms. Riess said, citing Bank of America’s recent moves to exit certain businesses and sell assets deemed one-core.

Consumer advocates have argued the products provide little financial benefit to consumers, and customers have alleged in lawsuits that banks’ sales agents have enrolled them in the services without their consent and mischaracterized their costs and features.

Capital One’s settlement with the Consumer Financial Protection Bureau and Office of the Comptroller of the Currency could prompt other banks to eliminate or alter payment protection and other add-on products, such as identity-theft protection and credit monitoring, experts said.  Under the settlement, Capital One agreed to refund $150 million to customers and pay $60 million in fines.

The issues surrounding Capital One’s actions were “not unique to a single institution, and we do expect that there will be more activity,” Richard Cordray, director of the CFPB, said last month.  The agency issued a bulletin in July reminding banks of steps they should take to ensure payment protection and other add-on products are marketed appropriately to customers.

A CFPB spokeswoman declined to comment for this story.

J. P. Morgan Chas & Co. (JPM) stopped offering payment protection to new customers in October 2011, spokesman Paul Hartwick, wrote in an email Tuesday.

Existing J. P. Morgan customers who were enrolled in payment protection prior to that move would still continue to have it, Mr. Hartwick wrote.  “We do not have any intentions to end the program for those customers at this time,” he wrote.

Citi spokeswoman Emily Collins wrote in an email that the bank continually reviews its sales practices, controls and policies for marketing all products, including optional debt protection products.

Citi recently “paused tele-sales for our debt protection products and believe this action will allow us to fully complete voluntary review already under way, in line with new guidance recently issued by the CFPB,” Ms. Collins wrote.

While Bank of America does not disclose how much revenue such products generate, the Government Accountability Office said in a March 2011 report that consumers paid $2.4 billion in fees for payment-protection products in 2009.

The report looked at nine credit-car issuers, including Discover Financial Services (DFS), American Express Co. (AXP) and Bank of America, concluding that a “relatively small proportion of the fees consumers pay for debt-protection products is returned to them in tangible financial benefits.

Bank of America and other large banks have marketed payment protection as a safety net cardholders can rely on in the event they lose their jobs, encounter health problems or incur another hardship that prevents them from making their minimum monthly payment.  If such an event occurs, the service is supposed to suspend a borrower’s minimum monthly payments for a certain period of time.

“Credit Protection Plus is an optional Plan that can give you relief from your bank of America minimum monthly credit card payments when you need it most,” a Bank of America webpage states.  “It can help protect your Bank of America credit card account by canceling the minimum monthly payment for up to 18 months when times get tough or if you experience a life event such as getting married or purchasing a new home.”

Fees typically range from 85 cents to $1.35 per $100 of outstanding balance each month, the GAO said.  Bank of America charged 85 cents for every $100 of balance a customer carried, according to the company’s webpage.

The bank, which is the second-largest credit-card issuer based on outstanding loan balances, agreed to pay $20 million this summer to settle a class-action lawsuit alleging it mismarketed payment-protection products.  The settlement filed in U.S. District Court in San Francisco, received preliminary approval in July but awaits final approval.

The settlement does not require Bank of America to discontinue the products, which Ms. Riess and a court filing described as a business decision by the bank.  The settlement requires the bank to provide two months of credit protection to customers already enrolled in the services for free, though it has independently decided to do so for six months as it winds down the products, Ms. Riess said.  That should occur sometime next year, she added.

Capital One has no intention of selling payment protection or credit monitoring products “in the future because the economics of our credit-card business does not depend on revenues from add-on products,” Richard Fairbank, chairman and chief executive of the bank, said on an earnings conference call last month.

Mr. Fairbank said Capital One’s third-party vendors “did nto uniformly adhere to our sales scripts and the explicit instructions we provided to agents for how these products should be sold.”

Discover also expects the CFPB and Federal Deposit Insurance corp. to take a joint enforcement action against it regarding its marketing of payment protection and other add-on products.  The company said in a filing with the Securities and Exchange Commission in June that the cost of such an action could exceed what it has already accrued for litigation and regulatory matters by $110 million.

The Riverwoods, Ill.-based lender generated $101.2 million in revenue from payment protection, ID-theft protection and other add-on products in its fiscal second quarter.  The amount was down 3.7% from a year earlier, which the company attributed to changes it has made to sales practices based on regulator feedback.

Discover continues to offer the products to customers according to spokesman Jon Drummond, who declined to comment on the company’s sales strategy.

In addition to eliminating payment-protection products, Bank of America also stopped offering ID-theft protection services to credit-card customers late last year, Ms. Riess said.

Bank of America has received inquiries from regulatory authorities regarding ID-theft protection services, “including customers who may have paid for but did not receive” certain services from third-party vendors, the company said in a filing with the SEC earlier this month.

Discover, like Bank of America, settled class-action litigation alleging it enrolled customers in payment-protection services without their consent and misrepresented product features when pitching them to consumers.  J. P. Morgan, Capital One and HSBC Holdings PLC (HBC) have also reached settlements in similar litigation in the last two years.

Richard Golomb, a plaintiffs’ attorney involved in those cases, said he does not expect many banks will eliminate such products entirely.

“I think these banks and credit-card companies will try to do anything to generate revenue to the extend that they can, and … until it doesn’t make sense for them to do it anymore they’ll continue to do it, “ said Mr. Golomb, a managing shareholder of the law firm of Golomb & Honik, PC.

Consumer Watchdog Fines Capital One for Deceptive Credit Card Practices

The New York Times

July 18, 2012

 

Capital One – which is known for its catchy television ads with Alec Baldwin – received a regulatory rebuke for misleading customers.

The nation’s consumer watchdog on Wednesday delivered its first enforcement action against the financial industry, fining Capital One for pressuring and misleading more than two million credit card customers.

Caption One, one of the nations biggest bans and credit card lenders, agreed to pay $210 million to resolve a pair of regulatory cases, the latest legal setback for the financial industry.

The Consumer Financial Protection Bureau, Wall Street’s newest regulator, accused Capital One of “deceptive marketing tactics.”  The credit card company – which is known for its catchy television ads, asking “what’s in your wallet” – received a regulatory rebuke for misleading card customers into buying unnecessary products like payment protection and credit monitoring, according to the consumer agency.

As part of the deal with the consumer bureau, Capital One must reimburse about $140 million to customers.  In a separate legal action, the Office of the Comptroller of the Currency, which regulates national banks, also sanctioned Capital One for bogus billing practices that spanned nearly a decade.

“We are putting companies on notice that these deceptive practices are against the law and will not be tolerated,” said Richard Cordray, the director of the consumer bureau.  Before Mr. Cordray became director of the bureau, he ran its enforcement division.

In a statement on Wednesday, Capital One said the wrongdoing occurred at outside call centers that “did not always adhere to company sales scripts.”  But the bank’s president of credit cards, Ryan M. Schneider, also acknowledged that the company was “accountable for the actions that vendors take on our behalf.”

“We apologize to those customers who were impacted and we are committed to making it right,” Mr Schneider said.

The case against Capital One could be the first of many actions against lenders that are aggressively ramping up payment-protection insurance programs, consumer advocates say.  The insurance, which promises card holders that the lender will suspend any late charges and minimum payments, has become particularly attractive in the depths of the recession.  While costs vary by card issuer, credit card companies typically charge up to 80 cents for every $100 of debt that is insured, lawyers for consumers said.

Banks are pushing into these products, according to industry analysts, in part to recoup billions in lost income resulting from new federal curbs on debit and credit-card fees.

The regulatory scrutiny comes on the heels of several Wall Street blowups and federal investigations that have stoked the anger of consumers and investors.  Last month, Barclays agreed to pay authorities $450 million to settle accusations that it had manipulated a benchmark interest rate, the first case to stem from a wide-ranging investigation into wrongdoing across the financial sector.  JPMorgan Chase is dealing with the fallout from a multibillion-dollar trading debacle.

The Captital One action was the consumer bureau’s first attempt to exercise its enforcement muscle.  Its case also comes on the second anniversary of the bureau’s creation, demonstrating the rapid growth of the nascent agency.

A centerpiece of the Dodd-Frank regulatory overhaul law passed in the wake of the financial crisis, the bureau is charged with protecting consumers from financial malfeasance.  The agency can write rules for an array of financial products, including credit cards and mortgages, as well as file enforcement actions against banks and the previously unregulated corners of the financial world like payday lenders

In the Capital One case, regulators say the bank allowed its call centers to deceptively sell certain credit card products to customers.  The products included a plan to allow customers to seek protection from bills if they lost their job – and debt forgiveness in the case of death or permanent disability.  The bank also offered credit monitoring, a feature that came with identity-theft protection and “credit education” for customers with spotty borrowing history.

In a 30-page order, the consumer bureau outlined how the bank’s call centers marketed and sold the products to ineligible unemployed consumers, who despite paying for the services, never received the full benefits.  At some call centers, a vendor working for the bank imposed the products without the consumer’s consent.  In other cases, according to the bureau, the bank employed “high pressure tactics,” including misleading customers into thinking the product was free, mandatory and would bolster credit scores.

Under the deal with regulators, Capital One must halt the deceptive practices and submit to an independent audit.  The deal also requires the bank to fully repay its customers who fell victim to the scheme.

In a related action on Wednesday, the Office of the Comptroller of the Currency required the bank to reimburse customers “harmed by unfair billing practices” that unfolded over a 10-year span, from 2002 to June of last year.  The O.C.C. imposed a $35 million fine against Capital One.

“Unfair and deceptive practices will not be tolerated,” Thomas J. Curry, the comptroller, said on Wednesday.

Between the restitution to customers and the fines to regulators, the bank will pay $210 million to settle the actions.

Capital One has run afoul of regulators before.  The bank, based in McLean, Va., was cited by the O.C.C. in 2010 for imposing “unfair” fees after customers sought to close their accounts.

The bank is also a longtime foe of consumer advocacy groups like the National Community Reinvestment Coalition.  The consumer groups have assailed the bank for its subprime and risky lending, while painting its credit card business as overly aggressive.  About a third of Capital One’s credit card portfolio carries the subprime label, defined as loans to borrowers with credit scores below 660, the company said last year.

The consumer bureau’s case against Capital One, which centers on credit card practices, comes as the bank has been ramping up its card business.  The bank closed a deal this year to buy HSBC’s American credit card business.

The National Community Reinvestment Coalition led the charge last year against Capital One’s bid to take over ING’s online banking unit in the United States, saying the deal would create the next too-big-too-fail banking behemoth.  The deal, the latest in a string of acquisitions, transformed Capital One into the fifth-largest bank by deposits.

While the Federal Reserve approved the deal, the consent came with some crucial conditions.  The Fed, citing consumer complaints and legal actions against the bank, ordered Capital One to bolster its internal controls of lending and debt-collection practices.

Top state law enforcement officials are also turning their attention to Capital One and other banks that pitch payment protection insurance.

Earlier this year, David M. Louie, Hawaii’s attorney general, sued seven major banks, including Capital One, for purportedly targeting elderly cardholders with payment protection plans.  The plans are ‘virtually worthless,” Mr. Louie said.

Credit card companies take advantage of consumers by signing them up for the protection without their permission, according to Mr. Louie.  The aggressive practice is particularly egregious, the attorney general’s office said, because the banks are pitching the products to their existing customers and have their sensitive card information.

“This practice is hardly limited to Capital One,” said Richard Golomb, a lawyer in Philadelphia who has brought class action lawsuits against lenders, including Bank of America, Citigroup, Discover Financial and JPMorgan Chase for credit protection insurance.

Federal Judge Approves Settlement in Generic-Antidepressant Class Action

Legal Intlligencer
By:  Amaris Elliott-Engel
July 5, 2012

A federal trial judge has approved the national settlement of a multidistrict litigation class action alleging that the generic version of the popular antidepressant drug Wellbutrin was not as therapeutically effective as the brand-name drug.  He also took a shot at a landmark U.S. Supreme Court decision in the process.

The drug makers agreed to give injunctive relief to the class by changing their product labels and taking other measures that the plaintiffs say will protect consumers.  A total of $4.5 million in attorney fees and class counsel costs also was approved.

As U. S. District Judge Berle M. Schiller of the Eastern District of Pennsylvania approved the settlement in In re Budeprion XL Marketing and Sales Litigation on Monday, he said that the settlement was prudent because the plaintiffs faced serious risks to establishing liability in the wake of a landmark U.S. Supreme Court ruling that sharply curtained the claims that pharmaceutical plaintiffs can make against generic drugmakers over drug warnings.

“The class faced the very real possibility of walking away with nothing,” Schiller said.

The settlement comes just over a year after the U.S. Supreme Court’s decision in Pliva v. Mensing.

Because the Supreme Court held that a generic-drug manufacturer “was foreclosed by federal law from changing its label without” the approval of the federal Food and Drug Administration and cannot abide by stronger requirements under state law, consumers who take generic drugs are stripped of their right to compensation, Schiller said.

“An individual’s ability to sue for damages caused by prescription medication should not depend on whether the drug was a name brand or a generic,” Schiller said.  “If drug manufacturers are legally responsible for their products (like every other maker of a good), generic-drug makers should not be immune from liability.

“The Supreme Court decision renders generic-drug makers parrots, free from liability provided they do a competent job copying the label of the name-brand-drug maker’s label.”

The judge approved $3.2 million in attorney fees, $1.3 million in class counsel costs, incentive awards of $10,000 to two class representatives and $5,000 to other named plaintiffs.

Schiller said the attorney fees were reasonable because the lodestar would result in $6.7 million in attorney fees, but class counsel asked for $3.2 million, “mindful of the lack of a monetary recovery for individual class members” and how their case was undercut by the Mensing decision.

The parties agreed to settle the plaintiffs’ claims regarding the defendants’ business practices under California’s Unfair Competition Law and under the California Consumer Legal Remedies Act.  The total member of class members is estimated to be as many as 2.24 million people.

The plaintiffs claim that defendants Teva Pharmaceuticals and Impax Laboratories Inc., respectively, distributed and made a generic formulation of the antidepressant Wellbutrin that was not as therapeutically effective, according to the plaintiffs’ memorandum in support of preliminary approval of the proposed class action settlement.

Bupropion hydrochloride is the active ingredient in Wellbutrin.

Defendant Impax Laboratories Inc. makes a generic version of Wellbutrin that uses a “matrix technology” that relies on the size of the pill to release the medication, and that generic reaches peak concentration in the human body in two hours.  Schiller said.  In contrast, other generics use a membrane-release technology so that the active ingredient seeps through a membrane that “actually passes through the entire GI [gastrointestinal] tract intact,” does not involve “dose dumping” and reaches peak concentration in five hours, the judge said.

Defendant Teva Pharmaceuticals distributes Impact’s generic version of Wellbutrin.

The plaintiffs claim that the labels on the defendants’ generics indicated that they were equivalent therapeutically to Wellbutrin, including that they would reach peak concentration in the bloodstream of the human body in five hours, not just two hours, Schiller said.  The plaintiffs also said, among other claims, that the defendants failed to disclose that taking the defendants’ generic versions with food increases the amount of the drug released into the body; that a 300-milligram version of the generic drug was never tested as bioequivalent with Wellbutrin; and that the defendants’ generics employ “an inferior release technology,” Schiller said.

“The representative plaintiffs all took defendants products to treat their depression but their symptoms instead worsened,” Schiller said when finding that the typicality prong had been established for the class.  “Had they known that the differences in defendants’ products rendered them useless as antidepressants, plaintiffs would have not purchased defendants’ medication.  Defendants failed to disclose important information to consumers, in violation of California consumer protection laws.”

The judge, however, said that it was “close” as to whether the class met the dictates of Federal Rule of Civil Procedure 23(b), which requires that injunctive relief should only be granted if a single injunction would provide relief to each class member.  One objection to the settlement was that the class counsel also sought monetary damages.

Schiller said that the request for statutory damages does not foreclose a settlement class under Rule 23(b)(2) because statutory damages “avoid an individualized calculation of damages.  Plaintiffs also proposed a complicated mechanism whereby restitution damages could be calculated for the entire class.”

The objections to the settlement included the Texas attorney general’s objection that the settlement “is akin to a coupon settlement with attorneys receiving all the proceeds,” and Jaquelyn Anderson’s objection that people who have stopped using the drug receive no benefit from the injunctive relief and the attorney fees requested are disproportionate to the benefits obtained for the class.

Plaintiffs counsel were Richard M. Golomb, Ruben Honik and Kenneth Grunfeld of Golomb & Honik in Philadelphia; Allan Kanner and Conlee S. Whiteley of Kanner & Whiteley in New Orleans; Gillian Wade of Milstein Adelman in Santa Monica, Calif.; Brian Ku and M. Ryan Casey of Ku & Mussman in Miami; and John Vail and Lou Bograd of the Center for Constitutional Litigation in Washington, D.C.

Kanner was lead counsel and Golomb & Honik was liaison counsel.

Impax laboratories defense counsel was Asim M. Bhansali of Keker & Van Nest in San Francisco, and Teva Pharmaceuticals defense counsel was Joseph Serino Jr. of Kirkland & Ellis in New York.

Attorneys for the defense could not be immediately reached for comment Tuesday.

“We are pleased with the injunctive relief we were able to provide to the class in the form of label changes and quality control and thank Judge Schiller who was very involved every step of the way,” Golomb said in an email.

Golomb & Honik named As Finalists For national Award As Attorneys Who Held Banks Accountable For unfair Customer Charges

June 21, 2012

News Release

A legal team that held some of the nation’s largest banks accountable for an accounting trick that charged customers unfair fees has been named a finalist for the 2012 Trial Lawyer of the Year Award, an honor presented annually by the Public Justice Foundation.

Lead counsel Bruce Rogow of Miami, Fla., and Aaron Podhurst of Podhurst Orseck in Miami, and co-counsel Robert Gilbert of Grossman Roth in Coral Gables, Fla., represented wronged consumers against three dozen banks, and won a number of significant settlements-Bank of America will pay $410 million and JPMorgan $110 million, among others.

Other members of the legal team included Robert Josefsberg, Peter Prieto and John Gravante, III, of Podhurst Orseck; Stuart Grossman, David Buckner and Seth Miles of Grossman Roth; Russell Budd, Bruce Steckler and Mazin Sbaiti of Baron & Budd in Dallas, Texas; Michael Sobol, David Stellings, Roger Heller and Jordon Elias of Lieff Crabraser Heimann & Bernstein in San Francisco; Ted Trief and Barbara Olk of Trief & Olk in New York City; Edward Adam Webb, Mathew Klase and G. Franklin Lemond, Jr. of Webb, Klase & Lemond in Atlanta; Richard Golomb, Ruben Honik and Kenneth Grunfeld of Golomb & Honik in Philadelphia; and Jeremy Alters of Alters Law Firm in Miami.

The settlements will provide refunds to millions of consumers charged unfair overdraft fees by their banks.  By rearranging debit transactions from highest to lowest, the banks drew down their customers’ account balances more rapidly.  The smallest transactions were posted last, and each one had the effect of overdrafting the account.  Since banks charge per overdraft, customers were hit with multiple fees.  Banks made around $29 billion a year from the fees.

Rogow, Podhurst, Gilbert and their co-counsel are among 42 total lawyers-involved in four cases-named as finalists for their extraordinary legal work in the public interest.  Fourteen cases were nominated for this year’s award.  They involve a range of issues, from a nationwide class action on behalf of female financial advisors discriminated against, to fighting for the First Amendment rights of watchdog journalist in Nevada.

The winner of the nationally prestigious award will be announced on July 31 at the Public Justice Foundation Annual Gala and Awards Dinner in Chicago.

 

 

Merck Hit With Antitrust Class Action Over Vaccine Data

By Matt Fair

Law 360, New York (June 25, 2012, 505 PM ET) – Merck and Co. Inc. was hit with a putative antitrust class action in Pennsylvania federal court Friday by an Alabama medical provider alleging the pharmaceutical company lied about the efficacy rate of its mumps inoculation in an effort to keep competitors from bringing their own versions of the vaccine to market.

Chatom Primary Care PC accuses Merck of concealing test results and falsifying studies to artificially maintain the vaccine’s claimed 95 percent efficacy rate and intimidate rivals from producing their own version.  Since 1967, Merck has been the sole pharmaceutical company in the U.S. licensed to produce mumps vaccine.

“Merck has maintained this monopoly not through its legitimate business acumen and innovation or its manufacture and sale of the safest, most effective and most cost-effective Mumps vaccine in the market,” the complaint said.  “Instead, Merck has willfully and illegally maintained its monopoly through its ongoing manipulation of the efficacy of its Mumps vaccine.”

The complaint comes in the wake of a False Claims Act case brought by two former Merck employees similarly alleging the company used improper testing techniques and falsified vaccine data to artificially inflate the efficacy rate of its mumps vaccine.  That case was unsealed in Pennsylvania federal court June 19 after the federal government declined to intervene.

The two employees said the government, which purchases more than half of the mumps vaccines produced by Merck, has spent hundreds of millions of dollars on ineffective medicine.

While substantially mirroring the allegations raised in the ongoing False Claims Act case, the putative class action filed Friday alleges that Merck’s behavior resulted in artificially high vaccine prices by effectively barring competitors from manufacturing their own vaccines.

“As with the market for any product, a potential competitor’s decision to enter a market hinges on whether its product can complete with those products already being sold in the market,” the complaint said.  “ If an existing vaccine is represented as safe and at least 95 percent effective, as Merck has falsely represented its vaccine to be, it would be economically irrational for a potential competitor to bring a new Mumps vaccine to the relevant market.”

Officials from Merck rejected the suits Monday, pointing out that the government declined to get involved in the FCA case after its own two-year investigation.

“This lawsuit is completely without merit, and we intend to vigorously defend against the allegations,” Merck spokesman Ron Rogers said.  “Nothing is more important to Merck than the safety and efficacy of our vaccines and the people who use them.”

Friday’s complaint says Merck’s mumps vaccine, which it incorporates into its MMRII and ProQuad inoculations, has lost significant potency over time and failed to prevent significant mumps outbreaks in the U.S. in 2006 and 2009.  In addition to mumps, the vaccines are intended to immunize recipients against measles, chickenpox and rubella.

In 2006, more than 6,500 mumps cases were reported in the Midwest, the suit says.  According to the complaint, 84 percent of the young adults who contracted the disease at the time were vaccinated against it.  Another 5,000 cases were reported across the country in 2009, the complaint says.

The vaccine contains a sample of the mumps virus strong enough to trigger an immune response in humans – thereby generating immunity – but too weak to cause serious illness.

However, as the vaccine has been synthesized repeatedly from the same strain of the mumps virus since its first manufacture in 1967, it has slowly become less and less potent over time, the complaint says, adding that Merck has been aware of the vaccine’s shortcomings for more than a decade.

“Merck knew and understood that the continued passaging of the attenuated virus from which its Mumps vaccine was created (over 40 years ago) had altered the virus and degraded its efficacy,” the complaint said.

When tests showed the vaccine was losing its effectiveness, the complaint says, Merck concealed the results and devised new studies with “scientifically flawed methodology” in an effort to get the outcome it wanted.

“The goal of this new efficacy testing was to support its original efficacy findings at all costs, including the use of scientifically flawed methodology and falsified test results,” the complaint said.

Chatom seeks to represent anyone who purchased mumps vaccines from Merck between Jan. 1, 1999, and the present.

The suit levies accusations against Merck of unjust enrichment, antitrust violations, breaking state consumer protection and warrants laws across the U.S.  It seeks treble damages under federal antitrust laws as well as equitable relief for class members.

Chatom Primary Care PC is represented by Richard Golomb and Steven Resnick of Golomb & Honik, PC, Hollis Salzman, Bernard Persky, Christopher McDonald, Kellie Lerner and Elizabeth Friedman of Labaton Sucharow LLP (/firms/labaton-sucharow), Stephen Dampier of Dampier Law Firm PC, and R. Edward Massey Jr. of  Clay Massey & Associates PC.

Counsel information for Merck was not immediately available.

The case is Chatom Primary Care PC v. Merck & Co (/companies/merck-co-inc). Inc., case number 2:12-cv-03555, in U.S. District Court for the Eastern District of Pennsylvania.

–Additional reporting by Lana Birbrair. Editing by Jocelyn Allison and Lindsay Naylor.

215.985.9177 | 800.355.3300

1515 Market Street , Suite 1100 Philadelphia, PA 19102